We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $783M
1-Year Est. Return 81.58%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
Cap. Flow
-$22.1M
Cap. Flow %
-2.82%
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62

Top Buys

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$6.96M
2
MYRG icon
MYR Group
MYRG
+$4.57M
3
DRS icon
Leonardo DRS
DRS
+$4.16M
4
SMTC icon
Semtech
SMTC
+$3.99M
5
P
Everpure Inc
P
+$3.43M

Top Sells

Rank Stock Value
1
CPRX
Catalyst Pharmaceutical
CPRX
+$11.2M
2
BAP icon
Credicorp
BAP
+$9.17M
3
NXT icon
Nextpower Inc. Common Stock
NXT
+$6.93M
4
XP icon
XP
XP
+$6.54M
5
STRL icon
Sterling Infrastructure
STRL
+$5.21M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Industrials 19.78%
3 Financials 17.73%
4 Healthcare 17.14%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INTU icon
276
Intuit
INTU
$83.7B
$303K 0.04%
+1,161
New +$404K
ATLC icon
277
Atlanticus Holdings
ATLC
$1.44B
$297K 0.04%
2,908
– –
OII icon
278
Oceaneering
OII
$4.6B
$295K 0.04%
7,283
– –
TPR icon
279
Tapestry
TPR
$23.1B
$287K 0.04%
1,960
– –
BGC icon
280
BGC Group
BGC
$5.7B
$285K 0.04%
26,687
+194
+0.7% +$2.17K
BKTI icon
281
BK Technologies
BKTI
$273M
$284K 0.04%
3,300
– –
CTBI icon
282
Community Trust Bancorp
CTBI
$1.38B
$284K 0.04%
3,920
+127
+3% +$8.46K
AMN icon
283
AMN Healthcare
AMN
$1.34B
$282K 0.04%
8,707
+1,578
+22% +$40.7K
ESTC icon
284
Elastic
ESTC
$9.34B
$281K 0.04%
4,925
+3,044
+162% +$163K
CMP icon
285
Compass Minerals
CMP
$1B
$281K 0.04%
9,020
– –
JCI icon
286
Johnson Controls International
JCI
$85.4B
$280K 0.04%
1,919
– –
IQV icon
287
IQVIA
IQV
$44.3B
$271K 0.03%
1,405
– –
CMTL icon
288
Comtech Telecommunications
CMTL
$45.5M
$269K 0.03%
128,019
-69,101
-35% -$266K
TACT icon
289
Transact Technologies
TACT
$53.6M
$258K 0.03%
44,123
– –
THFF icon
290
First Financial Corp
THFF
$917M
$252K 0.03%
3,254
– –
SRPT icon
291
Sarepta Therapeutics
SRPT
$2.18B
$251K 0.03%
13,985
– –
MD icon
292
Pediatrix Medical
MD
$2.07B
$248K 0.03%
9,804
– –
FLYW icon
293
Flywire
FLYW
$2.16B
$247K 0.03%
+14,086
New +$208K
LCII icon
294
LCI Industries
LCII
$2.1B
$247K 0.03%
2,335
-2,784
-54% -$306K
PLMR icon
295
Palomar
PLMR
$3.61B
$241K 0.03%
1,909
– –
XHR
296
Xenia Hotels & Resorts
XHR
$1.63B
$240K 0.03%
11,797
– –
GLOB icon
297
Globant
GLOB
$1.63B
$239K 0.03%
8,272
– –
VIRT icon
298
Virtu Financial
VIRT
$5.06B
$232K 0.03%
3,890
– –
LAMR icon
299
Lamar Advertising Co
LAMR
$14.9B
$230K 0.03%
1,476
– –
DBD icon
300
Diebold Nixdorf
DBD
$2.16B
$228K 0.03%
2,687
– –
10 11
12
13 14

Similar funds

CC
Converium Capital Montreal $783M AUM
CCG
Chatham Capital Group Savannah, Georgia $783M AUM 31.99% 1-Year Est. Return
LF
Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return
LF
Lee Financial Dallas, Texas $783M AUM 23.98% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $783M AUM 19.25% 1-Year Est. Return
SFWA
Summit Financial Wealth Advisors Lafayette, Louisiana $782M AUM 24.35% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
CWP
CFM Wealth Partners Austin, Texas $783M AUM 47.07% 1-Year Est. Return

Globeflex Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Financials.

  • Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
  • Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
  • Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
  • Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
  • Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
  • Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
  • Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.